Cited by 66Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Global gene analysis of late secretory phase, eutopic endometrium does not provide the basis for a minimally invasive test of endometriosis

Sherwin, J.R.A., Sharkey, A.M., Mihalyi, A., Simsa, P., Catalano, R.D., D'Hooghe, T.M.·2008·Human Reproduction

Abstract

BACKGROUND: Endometriosis occurs in 10% of women and is currently diagnosed by invasive laparoscopic testing. We tested the hypothesis that endometrial gene expression in late secretory phase endometrium differs between patients with and without endometriosis. METHODS: Ten patients with laparoscopically proven endometriosis (minimal/mild n = 5 and moderate/severe n = 5) and six controls, underwent endometrial biopsy in the late secretory phase (Day 23 onwards). Microarray interrogation of eutopic endometrial gene expression was performed. RESULTS: Microarray data were obtained for all control samples and eight samples from the endometriosis patients (n = 4 minimal/mild, n = 4 moderate/severe disease). Eight genes were identified as up-regulated and one gene was down-regulated in all endometriotic samples (more than 1.75-fold, P < 0.01). Real-time PCR analysis of protocadherin-17 (PCDH17), protein tyrosine phosphatase, receptor type, R (PTPRR) and interleukin-6 signal transducer (IL6ST) expression validated the microarray findings. CONCLUSIONS: Expression of very few transcripts differs, in late secretory eutopic endometrium, between controls and patients with endometriosis. The median fold changes of these genes are small. No transcripts were identified that could discriminate between minimal/mild and moderate/severe endometriosis. Therefore, interrogation of the late secretory endometrial transcriptome is not likely to form the basis of a minimally invasive diagnostic test for endometriosis.

Integrity signals

Registry

Crossref · 10.1093/humrep/den078

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Significant differences in gene expression exist in eutopic endometrium from women with versus without endometriosis at the transcript level.

    “At the transcript level, significant differences in gene expression exist in eutopic endometrium from women with versus without endometriosis [114–117].”

    From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [117]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sherwin, J. R. A., Sharkey, A. M., Mihalyi, A., Simsa, P., Catalano, R. D., & D'Hooghe, T. M.
Affiliations
  • Rosie Hospital (GB)
  • University of Cambridge (GB)
  • Universitair Ziekenhuis Leuven (BE)
Venue
Human Reproduction
Published
2008-05-01
Volume
23
Issue
5
Pages
1063-1068
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2091963543
Cited by
66
References
32
Citations by year
2025: 4 · 2024: 2 · 2023: 2 · 2020: 2 · 2019: 1 · 2018: 5 · 2017: 7 · 2016: 3 · 2015: 5 · 2014: 3 · 2013: 2 · 2012: 6
FWCI
9.29
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Cambridge
  • Biotechnology and Biological Sciences Research Council (8/EGH16 106)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometriosis, eutopic endometrium, endometrial gene expression, endometrial transcriptome, minimally invasive diagnosis, PTPRR, gp130, endometriosis severity
MeSH terms
Endometriosis, Endometrium, Female, Humans, Luteal Phase, Down-Regulation, Cadherins, Up-Regulation, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Cytokine Receptor gp130, Receptor-Like Protein Tyrosine Phosphatases, Class 7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review